Rachel Humphrey

EVP and Chief Medical Officer, Mirati Therapeutics, Inc.

Companies

Pyxis Oncology, Inc.Board member Aug 15, 2022 to now¹
Xilio Therapeutics, Inc.Board member Oct 21, 2021 to Oct 21, 2021²
Black Diamond Therapeutics, Inc.Chief Medical Officer Sep 10, 2020 to Feb 19, 2021³
CytomX Therapeutics, Inc.Chief Medical Officer Oct 7, 2015 to Jan 29, 2019⁴
Mirati Therapeutics, Inc.EVP and Chief Medical Officer Jul 12, 2013 to Jul 12, 2013⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Pyxis Oncology, Inc. PYXS81,309 shares⁶$142.3K at $1.75Apr 21, 2025
Xilio Therapeutics, Inc. XLO9,444 shares⁷$78.7K at $8.33Oct 21, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 21, 2025Sold 13,896 shares at $1.03 of Pyxis Oncology, Inc.⁶
Apr 17, 2025Sold 200 shares at $0.97 of Pyxis Oncology, Inc.⁶
Apr 14, 2025Sold 1,400 shares at $0.97 of Pyxis Oncology, Inc.⁶
Mar 26, 2024Granted 38,741 shares of Pyxis Oncology, Inc.⁸
Mar 24, 2023Granted 58,064 shares of Pyxis Oncology, Inc.⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPyxis Oncology, Inc., Board member
2
SEC EDGARXilio Therapeutics, Inc., Board member
3
SEC EDGARBlack Diamond Therapeutics, Inc., Chief Medical Officer
4
SEC EDGARCytomX Therapeutics, Inc., Chief Medical Officer
5
SEC EDGARMirati Therapeutics, Inc., EVP and Chief Medical Officer
6
SEC EDGARPyxis Oncology, Inc. shares after the filing of Apr 21, 2025
7
SEC EDGARXilio Therapeutics, Inc. shares after the filing of Oct 21, 2021
8
SEC EDGARForm 4 filed Mar 28, 2024
9
SEC EDGARForm 4 filed Mar 28, 2023